glp-1 long term side effects GLP-1RA Essentials in Gastroenterology: Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment what are the long term
Description
doi: 10.1016/j.bbrc.2016.07.095 38 LiY
Statements Author contributions The author searched the available literature on the topic using PubMed, Embase, clincal.trials.gov and is the sole independent author of this manuscript and its content
Mounjaro Mounjaro contains tirzepatide and acts not only on the GLP-1 receptor but also on the GIP receptor
Use in type 1 diabetes The ADJUNCT ONE trial (Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes), 55 the ADJUNCT TWO trial, 56 and a large meta-analysis 57 found reductions in hemoglobin A1c, body weight, and total daily dose of insulin, but also highlighted an increase in hyperglycemia with ketosis in patients with type 1 diabetes mellitus receiving liraglutide or exenatide in combination with insulin
furthermore, lifetime coverage of GLP-1s can greatly inflate plan sponsor expenses and be unsustainable
Most patients notice reduced appetite within the first two weeks and visible weight loss within four to six weeks
